Registration of the meeting of representatives of Sanofi with representatives of MZ SR, on 08.06.2015 at 10.00 p.m. at MZ SR

For MZ SR:

- Director General Department of Pharmacy and Drug Policy MUDr. Adam Hlôška
-Director Department of Classification, Pricing and Drug Policy PharmDr. Rastislav Pullmann
-reference Department of Classification, Pricing and Drug Policy IVDr. Erica Hanzelya

For Sanofi

Karin Takáčová
Ing. Štefan Chrenko

The meeting took place at the request of Sanofi Pasteur, which asked for a meeting.

The meeting was opened by the Director General of the Department of Pharmacy and Drug Policy Dr. Adam Hlôška.

Sanofi:

1. From 1 January to 31 December July 2015 will include the vaccine in the list of categorised medicinal products 39136 Vaxigrip 10x0.5. Technical solution for minimum supplement for vaccine 39 136 Vaxigrip 10x0.5 ml.

2. There are 93706 Verorab in the list of categorised medicines. The company would like raise the officially determined price of the medicinal product in question.

For MZ SR:

1. MZ SR can act on this subject only in accordance with current legislation of Slovakia and EU Law 363/2011 Order 435/2011 , as amended .

2. An increase in the official price of the product may occur within the meaning of the current legislation.

The sitting was closed by the Director-General of the Department of Pharmacy and Drug Policy Dr. Adam Hlôška.